HRT Financial’s REVIVA PHARMA HLDGS INC RVPH Stock Holding History

HRT Financial’s Portfolio RVPH Stock Details RVPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-18,423	Closed	-$13K	–	5197
2026 Q1	$13K	Buy	18,423 +16,867	+1,084%	+$76.7K	﹤0.01%	3614
2025 Q4	$8K	Buy	+1,556	New	+$17.3K	﹤0.01%	3051
2021 Q4	–	Sell	-673	Closed	-$54K	–	3952
2021 Q3	$54K	Buy	+673	New	+$53.1K	﹤0.01%	3035

Other funds holding RVPH

ECM

EMC Capital Management Houston, Texas $253M AUM

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $38B AUM 39.14% 1-Year Est. Return

PUI

Purpose Unlimited Inc Toronto $2.62B AUM

MGI

Miller Global Investments Dallas, Texas $121M AUM

MWM

Mosley Wealth Management Anaheim, California $314M AUM

HRT Financial's RVPH Position: Q2 2026 in Review

HRT Financial sold out of REVIVA PHARMA HLDGS INC (RVPH) in Q2 2026, closing a stake of 18,423 shares — an estimated $13K sold.

HRT Financial first reported a position in RVPH in Q3 2021 and held it in 3 quarters. The position peaked at $54K in Q3 2021. 5 funds tracked by Wall St. Rank hold RVPH as of Q2 2026.

HRT Financial reported no remaining REVIVA PHARMA HLDGS INC position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 18,423 REVIVA PHARMA HLDGS INC shares in Q2 2026, an estimated $13K.
HRT Financial first reported a position in REVIVA PHARMA HLDGS INC in Q3 2021 and held it in 3 quarters.
HRT Financial's REVIVA PHARMA HLDGS INC position peaked at $54K in Q3 2021.
5 funds tracked by Wall St. Rank held REVIVA PHARMA HLDGS INC as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.